iShares S&P Global HealthcareXHC.TOPAST TOP PICKMay 25, 2020Stock price when the opinion was issued
As of Jun 09, 2026. Market Open.
For healthcare, you really need to look south of the border. Limited offerings in Canada, where it's either marijuana or senior living.
Consider either IXJ or XHC, depending on what currency you want to purchase in. Broad-based, with major large-cap healthcare names. Pharma, healthcare products, services, and includes UNH. Likes the space, as you get both defensive and growth characteristics.
Yes, it is fairly steady, but healthcare is always subject to things happening from government (especially in the US) such as pricing pressure. So that could cause a bit of volatility.
An interesting way to play the sector. You're not chasing performance, and you're doing it in a balanced way. Good sector for this strategy, as it's not as economically sensitive as others.
Have some that's written and some that's not, so you don't give up all the upside. Healthcare hasn't participated in the market rally, but things should normalize with clarity in the US. Demographic trend is pretty good.
Tracks the S&P 1200 Global Health Care Sector Index. Large and diversified pharma, biotech, medical devices, health services. Giant scope. Names such as JNJ, UNH, PFE. Healthcare is often defensive, tailwind of aging population.
This sector's been a laggard, some of the names have really been hurt, so maybe there's a catchup trade. When we're in an environment of high beta and high growth, money rotates out of the defensive sectors.
Healthcare ETF. Playing the global healthcare space. BMO has one with a currency hedge on it. Thinks Healthcare will be a good bet for the next 20-30 years. You have to look at what is in them. Pharma vs. Biotech are different stories. This one is mostly large Pharma, which has its challenges. Should be bought about $30 where there is good support.
This is a global basket of health care stocks. Chart shows a little bit of a correction that took place in the early part of the year. Had a strong run at the beginning of the year which is very unusual for healthcare. There has been a pull back which is fine because it did so well earlier on. It is now getting back close to the top. We are into the seasonal period for healthcare, which is in August. We are just a few weeks away from that so this is an attractive sector.